title: Isoflurane-induced preconditioning is attenuated by diabetes.
abstract: Volatile anesthetics stimulate, but hyperglycemia attenuates, the activity of mitochondrial ATP-regulated K(+) channels. We tested the hypothesis that diabetes mellitus interferes with isoflurane-induced preconditioning. Acutely instrumented, barbiturate-anesthetized dogs were randomly assigned to receive 0, 0.32, or 0.64% end-tidal concentrations of isoflurane in the absence or presence of diabetes (3 wk after administration of alloxan and streptozotocin) in six experimental groups. All dogs were subjected to a 60-min left anterior descending coronary artery occlusion followed by 3 h of reperfusion. Myocardial infarct size (triphenyltetrazolium staining) was 29 +/- 3% (n = 8) of the left ventricular area at risk in control experiments. Isoflurane reduced infarct size (15 +/- 2 and 13 +/- 1% during 0.32 and 0.64% concentrations; n = 8 and 7 dogs, respectively). Diabetes alone did not alter infarct size (30 +/- 3%; n = 8) but blocked the protective effects of 0.32% (27 +/- 2%; n = 7) and not 0.64% isoflurane (18 +/- 3%; n = 7). Infarct size was directly related to blood glucose concentrations in diabetic dogs, but this relationship was abolished by higher concentrations of isoflurane. The results indicate that blood glucose and end-tidal isoflurane concentrations are important determinants of infarct size during anesthetic-induced preconditioning.
authors: Department of Anesthesiology, Milwaukee, Wisconsin 53226.
authors: Katsuya
authors: K
authors: Tanaka
authors: Franz
authors: F
authors: Kehl
authors: Weidong
authors: W
authors: Gu
authors: John G
authors: JG
authors: Krolikowski
authors: Paul S
authors: PS
authors: Pagel
authors: David C
authors: DC
authors: Warltier
authors: Judy R
authors: JR
authors: Kersten
mesh_terms: D018685:Anesthetics, Inhalation / Q000008:administration & dosage / Q000627:therapeutic use*; D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D003250:Constriction; D003331:Coronary Vessels; D003921:Diabetes Mellitus, Experimental / Q000150:complications*; D004285:Dogs; D005260:Female; D019194:Ischemic Preconditioning / Q000379:methods*; D007530:Isoflurane / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D009203:Myocardial Infarction / Q000473:pathology; D017202:Myocardial Ischemia / Q000503:physiopathology; D015428:Myocardial Reperfusion Injury / Q000150:complications* / Q000473:pathology / Q000517:prevention & control*
chemical_list: D018685:Anesthetics, Inhalation; D001786:Blood Glucose; D007530:Isoflurane